Hemodynamics After Endotracheal IntubationNCT07533643
Preoperative Topical Lidocaine Versus Intravenous Fentanyl to Obtund the Stress of Intubation Under Anesthesia.
A study testing topical lidocaine and Fentanyl (Low Dose) in people with Hemodynamics After Endotracheal Intubation, run by Kasr El Aini Hospital at 1 site in Egypt.
Trial summary
To compare the effectiveness of preoperative combined topical airway anesthesia consisting of nebulised, mouth rinsing and gargling with lidocaine versus intravenous fentanyl to prevent the stress of endotracheal intubation by direct laryngoscopy under general anesthesia. Read more about this study
- Who is it for?
- Ages 18 to 60 years
- Conditions the study is for
- Hemodynamics After Endotracheal Intubation
- What is being tested?
- topical lidocaine and Fentanyl (Low Dose)
- Type of treatment
- Injection or infusion
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 50 participants
- Where
- 1 siteEgypt
- Study dates
- 1 Aug 2025to 15 Nov 2025
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 60 years
- All sexes
- No healthy volunteers
- Adult
Who may be able to join
- American society of anaesthesiologists class 1 or 2 (ASA 1 or 2) patients.
- Patients undergoing elective surgeries under general anaesthesia with endotracheal intubation using direct laryngoscope.
- Population aged from 18 to 60 years.
Who cannot join
- Patient's refusal to participate.
- ASA class 3 or more patients including Substantive functional limitations; One or more moderate to severe diseases. Poorly controlled DM or HTN, COPD, morbid obesity (BMI ≥40), active hepatitis, alcohol dependence or abuse, implanted pacemaker, reduction of ejection fraction, ESRD undergoing regularly scheduled dialysis, history of MI, CVA, TIA, or CAD/stents, asthma with exacerbation, poorly controlled epilepsy.
- Patients with any degree of Hypertension or treated for hypertension.
- Pregnant patients.
- Age of participant less than 18 or more than 60 years.
- History of allergy to local anaesthetics or opioids.
Show all 13Show fewer
- Opioid abuse
- Anticipated difficult airway which will be defined as El-Ganzouri Risk Index (EGRI) score of 4 or more points.
- Difficult intubation which will be defined as situation where proper insertion of the tracheal tube with conventional laryngoscopy requires more than three attempts or more than 10 min.
- Difficult mask ventilation which will be defined as a situation that develops when it is not possible for the unassisted anaesthesiologist to maintain the oxygen saturation >90% using 100% oxygen and positive pressure ventilation, or to prevent or reverse signs of inadequate ventilation.
- Patients requiring more than one attempt of intubation.
- Intubation time more than 30 seconds.
- Emergency surgeries or patients requiring rapid sequence induction for other reasons.
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Preoperative Nebulized Lidocaine, Mouth Rinsing, and Gargling Versus Intravenous Fentanyl to Obtund the Stress of Intubation Under General Anesthesia.
To compare the effectiveness of preoperative combined topical airway anesthesia consisting of nebulised, mouth rinsing and gargling with lidocaine versus intravenous fentanyl to prevent the stress of endotracheal intubation by direct laryngoscopy under general anesthesia.
Read the detailed description
Methodology
- Study design Prospective randomized controlled trial. II. Study setting and location The study will be conducted in Kasr Al-Aini hospital (Cairo university hospitals) in elective surgical theatres.
III. Study population The study will be conducted on all elective surgical patients aged from 18 to 60 years requiring endotracheal intubation by direct laryngoscopy.
Total number of patients is 50 divided into two equal groups each containing 25 patients The two groups are group L (lidocaine) and group F (fentanyl). IV. Eligibility Criteria
- Inclusion criteria
- American society of anesthesiologists class 1 or 2 (ASA 1 or 2) patients.
- Patients undergoing elective surgeries under general anaesthesia with endotracheal intubation using direct laryngoscope.
- Population aged from 18 to 60 years.
- Exclusion criteria
- Patient's refusal to participate.
- ASA class 3 or more patients including substantive functional limitations; One or more moderate to severe diseases. Poorly controlled DM or HTN, COPD, morbid obesity (BMI ≥40), active hepatitis, alcohol dependence or abuse, implanted pacemaker, reduction of ejection fraction, ESRD undergoing regularly scheduled dialysis, history of MI, CVA, TIA, or CAD/stents, asthma with exacerbation, poorly controlled epilepsy.
- Patients with any degree of Hypertension or treated for hypertension.
- Pregnant patients.
- Age of participant less than 18 or more than 60 years.
- History of allergy to local anesthetics or opioids.
- Opioid abuse
- Anticipated difficult airway which will be defined as El-Ganzouri Risk Index (EGRI) score of 4 or more points.
- Difficult intubation which will be defined as situation where proper insertion of the tracheal tube with conventional laryngoscopy requires more than three attempts or more than 10 min.
- Difficult mask ventilation which will be defined as a situation that develops when it is not possible for the unassisted anesthesiologist to maintain the oxygen saturation >90% using 100% oxygen and positive pressure ventilation, or to prevent or reverse signs of inadequate ventilation.
- Patients requiring more than one attempt of intubation.
- Intubation time more than 30 seconds.
- Emergency surgeries or patients requiring rapid sequence induction for other reasons.
- Study Procedures
- Randomization (in RCT only)
Randomization will be carried out by a computer-generated list of random numbers then using closed envelope technique.
Total number of patients will be divided into two equal groups:
Each group will receive general anaesthesia using Propofol 1% 2 mg per kg and Atracurium besylate 0.5 mg per kg induction dose, however
- Group L (lidocaine group) will receive topical lidocaine for airway anaesthesia (before induction of general anesthesia) at a total dose of 4.5 mg per kg divided as nebulized lidocaine at a dose of 3 mg/kg and lidocaine mouth rinsing and gargling at a dose of 1.5 mg per kg.
- Group F (fentanyl group) will receive intravenous fentanyl at a dose 1 microgram per kg at induction of anesthesia.
- Study Protocol
All patients recruited into the study will undergo pre-operative anesthetic assessment, evaluation, planning, fasting and informed consent will be obtained from them.
Inside the preoperative holding area 20-gauge peripheral intravenous cannula will be inserted and secured after application of local antiseptic.
Pulse oximeter and non-invasive blood pressure readings will be taken. No sedative premedication will be given. Group L (lidocaine) will receive a total dose of 4.5 mg per kg topical lidocaine 2% divided as 3 mg per kg nebulized lidocaine and 1.5 mg per kg lidocaine will be diluted to a total volume of 25 cc water before mouth rinsing and gargling, process of mouth rinsing and gargling will continue for 3 minutes, then patients will go to the operating room, while Group F (fentanyl) will receive nebulized, mouth rinsed and gargled 0.9% sodium chloride (normal saline). All patients will be instructed not to swallow the oral solution used for mouth rinsing and gargling.
Thereafter continuous pulse oximeter (SPO2), non-invasive blood pressure and electrocardiogram monitors will be applied on the patients before induction of anesthesia. Baseline SBP, DBP, MAP and HR will be recorded.
Ventilator will be already checked while emergency drug (atropine and ephedrine), hypnotic agent prepared (Propofol 1%) and muscle relaxant (Atracurium besylate) will be prepared. Adequately sized ventilator mask and direct laryngoscope having curved blade will be prepared (Macintosh type) as well as endotracheal tube size 7 for female and 7.5 size for male patients.
Pre-oxygenation with 100% oxygen for 3 minutes will be done to all patients.
Induction of intravenous anesthesia in both groups will be as the following:
Group F will consist of normal saline (instead of fentanyl), 2 mg per kg propofol 1% and 0.5 mg per kg atracurium, while group F will receive 1 microgram per kg fentanyl (fentanyl Hameln Pharmaceutical Germany), 2 mg per kg propofol 1%, 0.5 mg per kg atracurium and drugs will be flushed using iv crystalloid infusion.
Volume control ventilation will be initiated after propofol administration with FIO2:100%, respiratory rate 12/ minute, tidal volume of about 8 ml/kg ideal body weight, I:E ratio of 1:2, flow meter is set at 5 L/min and peep of 5 cm H20. Isoflurane at 1.2 % will be used as maintenance inhalational agent. After 3 minutes of atracurium injection intubation will be started. Endotracheal tube size 7 to be inserted in female while size 7.5 in males. After confirmation of endotracheal tube position, hemodynamics readings (heart rate, systolic blood pressure, diastolic blood pressure and mean arterial pressure readings) will be taken immediately (1), 3, 6 and 10 minutes post intubation.
After extubation of each patient the incidence of laryngeal spasm will be noted while the patients will be asked about sore throat, dysphagia and hoarseness.
- Measurement tools
- Patients' characteristics: age, weight, sex and height.
- Clinical parameters: continuous peripheral oxygen saturation (SPO2) and ECG but non-invasive arterial blood pressure (NIBP) will be monitored as mentioned earlier.
- Postoperative laryngeal injuries will be assessed by asking the patients postoperatively about the presence or absence of sore throat, dysphagia and hoarseness. 4- Secondary outcomes:
- Systolic, diastolic and mean arterial blood pressure at 1, 3, 6 and 10 minutes post intubation.
- Heart rate immediately (1), 3, 6 and 10 minutes post intubation.
- Incidence of post-operative sore throat, dysphagia and hoarseness.
- Incidence of laryngeal spasm after extubation.
- Being tested
- topical lidocaine, Fentanyl (Low Dose)
- Keywords
- stress of intubation, Intubation , endotracheal, laryngoscopy, fentanyl, lidocaine
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
topical lidocaineDrug
topical lidocaine nebulized for 10 min + mouth rinsing and gargling for 3 min
Fentanyl (Low Dose)Drug
low dose fentanyl iv 1 mic per kg before induction
| Study group | Role | What they receive |
|---|---|---|
| Topical lidocaine | Experimental | nebulized lidocaine + mouth rinse + gargling dose 4.5mg per kg given pre-operatively drug topical lidocaine 2% topical lidocaine nebulized for 10 min + mouth rinsing and gargling for 3 min Receives: Drug: topical lidocaine |
| iv fentanyl | Active comparator | iv fentanyl dose 1 microgram per kg just before induction drug :Fentanyl citrate (0.05 mg/ml) (Fentanyl Hameln pharmaceutical, Germany) (Low Dose) low dose fentanyl iv 1 microgram per kg before induction Receives: Drug: Fentanyl (Low Dose) |
What is being measured
The primary outcome is the main question the study is designed to answer.
Maximum change in systolic blood pressure 5 minutes after endotracheal intubation from the baseline in both groups.
Automated non-invasive blood pressure monitor was used.
Measured: within 5 minutes post-intubation
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted16 Apr 2026
- Study start1 Aug 2025
- Primary completion20 Sep 2025
- Study completion15 Nov 2025
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Hemodynamics After Endotracheal IntubationStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind
- Who is masked
- Participant
- Enrolment
- 50 participants (actual)
Sponsor and investigators
- Lead sponsor
- Kasr El Aini Hospital
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Zeinab Mohamed Gamal El Deen Megaly, Kasr El Aini Hospital
- Investigators
- Mohamed Ahmed Mansour, professor, Principal investigator, Cairo UniversityShady Rady Abdalla, lecturer, Study director, Cairo Universitysherif Ismail Muhammed, lecturer, Study director, Cairo UniversityZeinab Mohammed Gamal, Resident, Study director, Cairo University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07533643
- Sponsor's protocol ID
- MS-300-2025
- Status last verified
- Apr 2026
- First submitted
- 10 Apr 2026
- Last updated
- 16 Apr 2026
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 16 Apr 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Preoperative Nebulized Lidocaine, Mouth Rinsing, and Gargling Versus Intravenous Fentanyl to Obtund the Stress of Intubation Under General Anesthesia.
- ClinicalTrials.gov ID
- NCT07533643
- Acronym / sponsor ID
- MS-300-2025
- Keywords
- stress of intubation, Intubation , endotracheal, laryngoscopy, fentanyl, lidocaine
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 50 participants (actual)
- Lead sponsor
- Kasr El Aini HospitalUniversity, hospital or other
- Study start
- 1 Aug 2025 (actual)
- Primary completion
- 20 Sep 2025 (actual)
- Study completion
- 15 Nov 2025 (actual)
- First posted
- 16 Apr 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
To compare the effectiveness of preoperative combined topical airway anesthesia consisting of nebulised, mouth rinsing and gargling with lidocaine versus intravenous fentanyl to prevent the stress of endotracheal intubation by direct laryngoscopy under general anesthesia.
Detailed description
Methodology
- Study design Prospective randomized controlled trial. II. Study setting and location The study will be conducted in Kasr Al-Aini hospital (Cairo university hospitals) in elective surgical theatres.
III. Study population The study will be conducted on all elective surgical patients aged from 18 to 60 years requiring endotracheal intubation by direct laryngoscopy.
Total number of patients is 50 divided into two equal groups each containing 25 patients The two groups are group L (lidocaine) and group F (fentanyl). IV. Eligibility Criteria
- Inclusion criteria
- American society of anesthesiologists class 1 or 2 (ASA 1 or 2) patients.
- Patients undergoing elective surgeries under general anaesthesia with endotracheal intubation using direct laryngoscope.
- Population aged from 18 to 60 years.
- Exclusion criteria
- Patient's refusal to participate.
- ASA class 3 or more patients including substantive functional limitations; One or more moderate to severe diseases. Poorly controlled DM or HTN, COPD, morbid obesity (BMI ≥40), active hepatitis, alcohol dependence or abuse, implanted pacemaker, reduction of ejection fraction, ESRD undergoing regularly scheduled dialysis, history of MI, CVA, TIA, or CAD/stents, asthma with exacerbation, poorly controlled epilepsy.
- Patients with any degree of Hypertension or treated for hypertension.
- Pregnant patients.
- Age of participant less than 18 or more than 60 years.
- History of allergy to local anesthetics or opioids.
- Opioid abuse
- Anticipated difficult airway which will be defined as El-Ganzouri Risk Index (EGRI) score of 4 or more points.
- Difficult intubation which will be defined as situation where proper insertion of the tracheal tube with conventional laryngoscopy requires more than three attempts or more than 10 min.
- Difficult mask ventilation which will be defined as a situation that develops when it is not possible for the unassisted anesthesiologist to maintain the oxygen saturation >90% using 100% oxygen and positive pressure ventilation, or to prevent or reverse signs of inadequate ventilation.
- Patients requiring more than one attempt of intubation.
- Intubation time more than 30 seconds.
- Emergency surgeries or patients requiring rapid sequence induction for other reasons.
- Study Procedures
- Randomization (in RCT only)
Randomization will be carried out by a computer-generated list of random numbers then using closed envelope technique.
Total number of patients will be divided into two equal groups:
Each group will receive general anaesthesia using Propofol 1% 2 mg per kg and Atracurium besylate 0.5 mg per kg induction dose, however
- Group L (lidocaine group) will receive topical lidocaine for airway anaesthesia (before induction of general anesthesia) at a total dose of 4.5 mg per kg divided as nebulized lidocaine at a dose of 3 mg/kg and lidocaine mouth rinsing and gargling at a dose of 1.5 mg per kg.
- Group F (fentanyl group) will receive intravenous fentanyl at a dose 1 microgram per kg at induction of anesthesia.
- Study Protocol
All patients recruited into the study will undergo pre-operative anesthetic assessment, evaluation, planning, fasting and informed consent will be obtained from them.
Inside the preoperative holding area 20-gauge peripheral intravenous cannula will be inserted and secured after application of local antiseptic.
Pulse oximeter and non-invasive blood pressure readings will be taken. No sedative premedication will be given. Group L (lidocaine) will receive a total dose of 4.5 mg per kg topical lidocaine 2% divided as 3 mg per kg nebulized lidocaine and 1.5 mg per kg lidocaine will be diluted to a total volume of 25 cc water before mouth rinsing and gargling, process of mouth rinsing and gargling will continue for 3 minutes, then patients will go to the operating room, while Group F (fentanyl) will receive nebulized, mouth rinsed and gargled 0.9% sodium chloride (normal saline). All patients will be instructed not to swallow the oral solution used for mouth rinsing and gargling.
Thereafter continuous pulse oximeter (SPO2), non-invasive blood pressure and electrocardiogram monitors will be applied on the patients before induction of anesthesia. Baseline SBP, DBP, MAP and HR will be recorded.
Ventilator will be already checked while emergency drug (atropine and ephedrine), hypnotic agent prepared (Propofol 1%) and muscle relaxant (Atracurium besylate) will be prepared. Adequately sized ventilator mask and direct laryngoscope having curved blade will be prepared (Macintosh type) as well as endotracheal tube size 7 for female and 7.5 size for male patients.
Pre-oxygenation with 100% oxygen for 3 minutes will be done to all patients.
Induction of intravenous anesthesia in both groups will be as the following:
Group F will consist of normal saline (instead of fentanyl), 2 mg per kg propofol 1% and 0.5 mg per kg atracurium, while group F will receive 1 microgram per kg fentanyl (fentanyl Hameln Pharmaceutical Germany), 2 mg per kg propofol 1%, 0.5 mg per kg atracurium and drugs will be flushed using iv crystalloid infusion.
Volume control ventilation will be initiated after propofol administration with FIO2:100%, respiratory rate 12/ minute, tidal volume of about 8 ml/kg ideal body weight, I:E ratio of 1:2, flow meter is set at 5 L/min and peep of 5 cm H20. Isoflurane at 1.2 % will be used as maintenance inhalational agent. After 3 minutes of atracurium injection intubation will be started. Endotracheal tube size 7 to be inserted in female while size 7.5 in males. After confirmation of endotracheal tube position, hemodynamics readings (heart rate, systolic blood pressure, diastolic blood pressure and mean arterial pressure readings) will be taken immediately (1), 3, 6 and 10 minutes post intubation.
After extubation of each patient the incidence of laryngeal spasm will be noted while the patients will be asked about sore throat, dysphagia and hoarseness.
- Measurement tools
- Patients' characteristics: age, weight, sex and height.
- Clinical parameters: continuous peripheral oxygen saturation (SPO2) and ECG but non-invasive arterial blood pressure (NIBP) will be monitored as mentioned earlier.
- Postoperative laryngeal injuries will be assessed by asking the patients postoperatively about the presence or absence of sore throat, dysphagia and hoarseness. 4- Secondary outcomes:
- Systolic, diastolic and mean arterial blood pressure at 1, 3, 6 and 10 minutes post intubation.
- Heart rate immediately (1), 3, 6 and 10 minutes post intubation.
- Incidence of post-operative sore throat, dysphagia and hoarseness.
- Incidence of laryngeal spasm after extubation.
Study design
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (participant)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Topical lidocaine | Experimental | Drug: topical lidocainenebulized lidocaine + mouth rinse + gargling dose 4.5mg per kg given pre-operatively drug topical lidocaine 2% topical lidocaine nebulized for 10 min + mouth rinsing and gargling for 3 min |
| iv fentanyl | Active comparator | Drug: Fentanyl (Low Dose)iv fentanyl dose 1 microgram per kg just before induction drug :Fentanyl citrate (0.05 mg/ml) (Fentanyl Hameln pharmaceutical, Germany) (Low Dose) low dose fentanyl iv 1 microgram per kg before induction |
Who may qualify
- Ages
- 18 to 60 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult
Key inclusion criteria (3 listed)
- American society of anaesthesiologists class 1 or 2 (ASA 1 or 2) patients.
- Patients undergoing elective surgeries under general anaesthesia with endotracheal intubation using direct laryngoscope.
- Population aged from 18 to 60 years.
Key exclusion criteria (13 listed)
- Patient's refusal to participate.
- ASA class 3 or more patients including Substantive functional limitations; One or more moderate to severe diseases. Poorly controlled DM or HTN, COPD, morbid obesity (BMI ≥40), active hepatitis, alcohol dependence or abuse, implanted pacemaker, reduction of ejection fraction, ESRD undergoing regularly scheduled dialysis, history of MI, CVA, TIA, or CAD/stents, asthma with exacerbation, poorly controlled epilepsy.
- Patients with any degree of Hypertension or treated for hypertension.
- Pregnant patients.
- Age of participant less than 18 or more than 60 years.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| topical lidocainetopical lidocaine nebulized for 10 min + mouth rinsing and gargling for 3 min | Drug | Topical lidocaine |
| Fentanyl (Low Dose)low dose fentanyl iv 1 mic per kg before induction | Drug | iv fentanyl |
Primary outcome
Maximum change in systolic blood pressure 5 minutes after endotracheal intubation from the baseline in both groups.
Time frame: within 5 minutes post-intubation
Automated non-invasive blood pressure monitor was used.
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 16 Apr 2026.
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Mohamed Ahmed Mansour, professor principal investigator
Cairo University
Shady Rady Abdalla, lecturer study director
Cairo University
sherif Ismail Muhammed, lecturer study director
Cairo University
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing topical lidocaine and Fentanyl (Low Dose) in people with Hemodynamics After Endotracheal Intubation, run by Kasr El Aini Hospital at 1 site in Egypt.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 13 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 16 Apr 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Maximum change in systolic blood pressure 5 minutes after endotracheal intubation from the baseline in both groups. (time frame: within 5 minutes post-intubation). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Apr 2026.